Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira," "Inspira Technologies" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that its U.

Patients with chronic kidney disease (CKD) often encounter cardiovascular complications, most commonly coronary heart disease. Although coronary artery bypass grafting is an effective treatment for ...

Annie's parents, Richard and Rachel Bicknell of Windham, thought they'd have to travel to Boston for treatment but thanks to ...

The global coronary artery bypass graft market is projected to reach USD 18,700.6 million by 2025 and continue its upward trajectory with a CAGR of 2.9%, reaching approximately USD 24,887.3 million by ...

Heart bypass surgery is a new beginning for patients, significantly enhancing longevity and quality of life. It is performed when critical blockages a ...

FDA has granted CLPH-511 Fast Track Designation for the treatment of acute hemorrhage as an alternative to conventional ...

Cardiac and major vascular surgeries are intricate and high-risk procedures known for significant morbidity and mortality ...

Grant Williams has a different outlook on life since he was given a second a chance and never thought he would be able to ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Patients with chronic kidney disease (CKD) often encounter cardiovascular complications, most commonly ...